# Biosplice Therapeutics, Inc. clinical trials: 22 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials with Biosplice Therapeutics, Inc. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Biosplice Therapeutics, Inc.: 22 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/biosplice-therapeutics-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2022 | NCT05603754 | Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis (STRIDES) | Biosplice Therapeutics, Inc. | Phase 3 | Completed | Knee Osteoarthritis | 499 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05603754) |
| October 20, 2021 | NCT05084859 | A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or... | Biosplice Therapeutics, Inc. | Phase 1 | Terminated | Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Colorectal Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05084859) |
| June 18, 2021 | NCT04931667 | 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis | Biosplice Therapeutics, Inc. | Phase 3 | Terminated | Osteoarthritis of the Knee | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04931667) |
| October 22, 2020 | NCT04598542 | Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers | Biosplice Therapeutics, Inc. | Phase 1 | Completed | Drug-Drug Interaction | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04598542) |
| August 20, 2020 | NCT04520607 | A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee | Biosplice Therapeutics, Inc. | Phase 3 | Terminated | Osteoarthritis, Knee | 276 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04520607) |
| May 12, 2020 | NCT04385303 | Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1) | Biosplice Therapeutics, Inc. | Phase 3 | Completed | Knee Osteoarthritis | 496 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04385303) |
| April 26, 2019 | NCT03928184 | Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis | Biosplice Therapeutics, Inc. | Phase 3 | Completed | Knee Osteoarthritis | 501 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03928184) |
| November 15, 2018 | NCT03742518 | A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia | Biosplice Therapeutics, Inc. | Phase 2/3 | Completed | Androgenetic Alopecia | 675 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03742518) |
| November 1, 2018 | NCT03727022 | Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis | Biosplice Therapeutics, Inc. | Phase 2 | Completed | Knee Osteoarthritis | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03727022) |
| October 16, 2018 | NCT03706521 | MRI Study to Evaluate the Safety and Efficacy of SM04690 for Knee Osteoarthritis | Biosplice Therapeutics, Inc. | Phase 2 | Terminated | Knee Osteoarthritis | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03706521) |
| July 19, 2018 | NCT03591926 | A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic... | Biosplice Therapeutics, Inc. | Phase 2 | Withdrawn | Idiopathic Pulmonary Fibrosis | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03591926) |
| April 18, 2018 | NCT03502434 | A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers | Biosplice Therapeutics, Inc. | Phase 1 | Completed | Tendinopathy | 223 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03502434) |
| November 28, 2017 | NCT03355066 | A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors | Biosplice Therapeutics, Inc. | Phase 1 | Terminated | Solid Tumor, Adult | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03355066) |
| August 11, 2017 | NCT03246399 | A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in... | Biosplice Therapeutics, Inc. | Phase 1 | Terminated | Degenerative Disc Disease | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03246399) |
| July 25, 2017 | NCT03229291 | A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration... | Biosplice Therapeutics, Inc. | Phase 1 | Completed | Tendinopathy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03229291) |
| April 21, 2017 | NCT03122860 | A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis | Biosplice Therapeutics, Inc. | Phase 2 | Completed | Knee Osteoarthritis | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03122860) |
| November 1, 2016 | NCT02951026 | An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the... | Biosplice Therapeutics, Inc. | Observational | Completed | Osteoarthritis | 703 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02951026) |
| September 1, 2015 | NCT02536833 | A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely... | Biosplice Therapeutics, Inc. | Phase 2 | Completed | Osteoarthritis | 455 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02536833) |
| July 20, 2015 | NCT02503137 | A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and... | Biosplice Therapeutics, Inc. | Phase 2 | Completed | Androgenetic Alopecia | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02503137) |
| October 27, 2014 | NCT02275351 | A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) | Biosplice Therapeutics, Inc. | Phase 2 | Completed | Androgenetic Alopecia | 302 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02275351) |
| July 16, 2014 | NCT02191761 | Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer | Biosplice Therapeutics, Inc. | Phase 1 | Completed | Colorectal Cancer, Gastric Cancer, Hepatic Cancer, Pancreatic Cancer | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02191761) |
| March 26, 2014 | NCT02095548 | Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe... | Biosplice Therapeutics, Inc. | Phase 1 | Completed | Moderate to Severe Osteoarthritis | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02095548) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 8 |
| Phase 2 | 7 |
| Phase 2/3 | 1 |
| Phase 3 | 5 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 15 |
| Terminated | 6 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Osteoarthritis | 9 |
| Osteoarthritis, Knee | 8 |
| Alopecia | 3 |
| Tendinopathy | 2 |
| Colorectal Neoplasms | 2 |
| Intervertebral Disc Degeneration | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Respiratory Aspiration | 1 |
| Stomach Neoplasms | 1 |
| Liver Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Insulation contractors in the United States](https://specstream.ai/data/businesses/insulation-contractors/united-states)
- [Cheesesteak restaurants in the United States](https://specstream.ai/data/businesses/cheesesteak-restaurants/united-states)
- [Tapas bars in the United States](https://specstream.ai/data/businesses/tapas-bars/united-states)
- [Lumber stores in the United States](https://specstream.ai/data/businesses/lumber-stores/united-states)
- [Damage restoration companies in the United States](https://specstream.ai/data/businesses/damage-restoration-companies/united-states)
- [Venezuelan restaurants in the United States](https://specstream.ai/data/businesses/venezuelan-restaurants/united-states)
